| 3.33 Real-Time Quote | +0.01 / +0.30%Today’s Change | 2.07 Today|||52-Week Range 4.05 | +27.26% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $481.8M |
AVANIR Pharmaceuticals, Inc. 20 Enterprise Aliso Viejo California 92656 |

| Keith A. Katkin, MBA, CPA | President, Chief Executive Officer & Director |
| Christine G. Ocampo, CPA | Secretary & Vice President-Finance |
| Randall E. Kaye, MD | Chief Medical Officer & SVP-Medical Affairs |
| Joao Siffert, MD, MBA | CSO, Senior VP-Research & Development |
| Rohan Palekar, MBA | Chief Commercial Officer & Senior Vice President |